OrbiMed Entities Execute $12.5 Million Stock Acquisition in Prelude Therapeutics
Several entities associated with OrbiMed Advisors LLC have significantly expanded their position in Prelude Therapeutics Inc (NASDAQ:PRLD). Through an underwritten public offering, these affiliated groups acquired 2,815,315 shares of common stock on April 21, 2026. This transaction represents a total investment of approximately $12,499,998, with th…